# Stage Handoff

- From: Step 4 — Korean Market Price Research
- To: Step 5 — Preliminary Filter
- Date: 2026-10-09
- Status: COMPLETED (user approved)

## Completed

- Collected 133 Korean seller/price-comparison quote observations for C001–C062.
- Produced price_summary.csv with one row per candidate.
- Differentiated normal advertised-price estimates (7), comparably listed new-product lows (47), conditional deals (20), and unavailable/unknown comparable low (15).
- Separated local genuine-category listings from overseas/import, out-of-stock, refurbished, open-box, and limited editions where identified.
- Recorded Step 4 sources E0143–E0199.

## Outputs

- research/04_price_research/result.md
- data/prices.csv
- data/price_summary.csv
- data/evidence.csv

## Key Findings

- Price snapshot is NOT confirmed seller checkout price, and normal-price estimates are not longitudinal transaction prices.
- HIFIMAN official shop displays sold-out prices, not usable live new-product lows.
- Some import listings look far cheaper than Korean genuine prices, but differ in warranty and transaction conditions.
- Confidence low/unknown for most candidates; avoid absolute cost/performance conclusions on unverified quotes.

## Open Questions

- Direct Naver Shopping/Blog access limited.
- Individual retailer inventory, delivery, taxes and warranty require final purchase confirmation.
- Price stability unavailable without sufficient historical observations.

## Known Uncertainty

- 15 candidate prices remain UNKNOWN.
- Only 7 approximate normal asking prices have independent cross-portal support.
- Some price pages are indexed/cached, not current cart offers.

## Required Inputs for Next Step

- Step 0 listening priorities
- data/candidates.csv
- data/price_summary.csv
- data/prices.csv
- research/03_product_status/result.md
- research/04_price_research/result.md
- RULES.md & plan/05_pre_filter.md

## Do Not Re-evaluate Unless

- Source prices age out or better seller quotes are observed.
- Category/variant/stock or distributor labels change.

## Next Exact Action

Perform staged low-cost technical/use-case and **evidence-backed price/performance** screening for all 62. Price alone must never reject a product; documented severe relative underperformance may REJECT only with price/usage-aligned alternatives and independent comparative evidence. Mark insufficient-evidence products HOLD and preserve for affordable further investigation.
